The ErbB3/HER3 Intracellular Domain is Competent to Bind ATP and Catalyze Autophosphorylation

Loading...
Thumbnail Image
Penn collection
Departmental Papers (BE)
Degree type
Discipline
Subject
Life Sciences
Medicine and Health Sciences
Funder
Grant number
License
Copyright date
Distributor
Contributor
Abstract

ErbB3/HER3 is one of four members of the human epidermal growth factor receptor (EGFR/HER) or ErbB receptor tyrosine kinase family. ErbB3 binds neuregulins via its extracellular region and signals primarily by heterodimerizing with ErbB2/HER2/Neu. A recently appreciated role for ErbB3 in resistance of tumor cells to EGFR/ErbB2-targeted therapeutics has made it a focus of attention. However, efforts to inactivate ErbB3 therapeutically in parallel with other ErbB receptors are challenging because its intracellular kinase domain is thought to be an inactive pseudokinase that lacks several key conserved (and catalytically important) residues-including the catalytic base aspartate. We report here that, despite these sequence alterations, ErbB3 retains sufficient kinase activity to robustly trans-autophosphorylate its intracellular region--although it is substantially less active than EGFR and does not phosphorylate exogenous peptides. The ErbB3 kinase domain binds ATP with a K(d) of approximately 1.1 microM. We describe a crystal structure of ErbB3 kinase bound to an ATP analogue, which resembles the inactive EGFR and ErbB4 kinase domains (but with a shortened alphaC-helix). Whereas mutations that destabilize this configuration activate EGFR and ErbB4 (and promote EGFR-dependent lung cancers), a similar mutation conversely inactivates ErbB3. Using quantum mechanics/molecular mechanics simulations, we delineate a reaction pathway for ErbB3-catalyzed phosphoryl transfer that does not require the conserved catalytic base and can be catalyzed by the "inactive-like" configuration observed crystallographically. These findings suggest that ErbB3 kinase activity within receptor dimers may be crucial for signaling and could represent an important therapeutic target.

Advisor
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Publication date
2010-04-27
Volume number
Issue number
Publisher
Publisher DOI
Journal Issue
Comments
Suggested Citation: Shi, Fuman,Shannon E. Telesco, Yingting Liu, Ravi Radhakrishnan, and Mark A. Lemmon. "ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation." PNAS 2010 107 (17) 7692-7697; published ahead of print March 29, 2010. doi:10.1073/pnas.1002753107
Recommended citation
Collection